Abstract
Cigarette smoke (CS), which increases inflammation and oxidative stress, is a major risk factor for the development of COPD. In this study, we investigated the effects of silymarin, a polyphenolic flavonoid isolated from the seeds and fruits of milk thistle, on CS-induced airway inflammation and oxidative stress in mice and the possible mechanisms. BALB/c mice were exposed to CS for 2 h twice daily, 6 days per week for 4 weeks. Silymarin (25, 50 mg/kg · day) was administered intraperitoneally 1 h before CS exposure. Bronchoalveolar lavage fluid (BALF) was acquired for cell counting and the detection of pro-inflammatory cytokine levels. Lung tissue was collected for histological examination, myeloperoxidase (MPO) activity assay, superoxide dismutase (SOD) activities, and malondialdehyde (MDA) levels. The phosphorylation of ERK and p38 was evaluated by Western blotting. Pretreatment with silymarin significantly attenuated CS-induced thickening of the airway epithelium, peribronchial inflammatory cell infiltration, and lumen obstruction. The numbers of total cells, macrophages, and neutrophils, along with the MPO activity (a marker of neutrophil accumulation) in BALF, were remarkably decreased by silymarin in CS-exposed mice (all p < 0.05). In addition, silymarin pretreatment dampened the secretion of TNF-α, IL-1β, and IL-8 in BALF. High-dose silymarin (50 mg/kg · day) administration also prevented CS-induced elevation in MDA levels and decrease in SOD activities (p < 0.05). Furthermore, the CS-induced phosphorylation of ERK and p38 was also attenuated by silymarin (p < 0.05). These results suggest that silymarin attenuated inflammation and oxidative stress induced by cigarette smoke. The anti-inflammatory effect might partly act through the mitogen-activated protein kinases (MAPK) pathway.
Similar content being viewed by others
References
Cosio, M.G., M. Saetta, and A. Agusti. 2009. Immunologic aspects of chronic obstructive pulmonary disease. New England Journal of Medicine 360(23): 2445–2454.
Taylor, J.D. 2010. COPD and the response of the lung to tobacco smoke exposure. Pulmonary Pharmacology & Therapeutics 23(5): 376–383.
Tetley, T.D. 2005. Inflammatory cells and chronic obstructive pulmonary disease. Current Drug Targets. Inflammation and Allergy 4(6): 607–618.
Milk Thistle (Silybum marianum) in PDR for herbal medicines. Montvale, NJ, Medical Economics Company, 2000: 516–520.
Yang T, Luo F, Shen YC, An J, Li XO, Liu XY, Ying BW, Liao ZL, Dong JJ, Guo LL, Wang T, Xu D, Chen L, Wen FQ. 2012. Quercetin attenuates airway inflammation and mucus production induced by cigarette smoke in rats. International Immunopharmacology
Song, Z., I. Deaciuc, M. Song, D.Y. Lee, Y. Liu, X. Ji, and C. McClain. 2006. Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcoholism, Clinical and Experimental Research 30(3): 407–413.
Zi, X., D.K. Feyes, and R. Agarwal. 1998. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Clinical Cancer Research 4(4): 1055–1064.
Féher, J., and G. Lengyel. 2012. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Current Pharmaceutical Biotechnology 13(1): 210–217.
Gazák, R., D. Walterová, and V. Kren. 2007. Silybin and silymarin-new and emerging applications in medicine. Current Medicinal Chemistry 14(3): 315–338.
Naveen, K.S., S. Garima, K.P. Devendra, K.J. Swatantra, and P.S. Mahendra. 2011. Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson’s disease phenotype in the mouse. Journal of Pineal Research 50: 97–109.
Chen, L., B.B. Sun, T. Wang, X. Wang, J.Q. Li, H.X. Wang, S.F. Zhang, D.S. Liu, L. Liu, D. Xu, X.M. Ou, Y.J. Chen, T. Yang, H. Zhou, and F.Q. Wen. 2010. Cigarette smoke enhances β-defensin 2 expression in rat airways via nuclear factor-κB activation. European Respiratory Journal 36(3): 638–645.
Toklu, H.Z., T. Tunali Akbay, A. Velioglu-Ogunc, F. Ercan, N. Gedik, M. Keyer-Uysal, and G. Sener. 2008. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. Journal of Surgical Research 145(2): 214–222.
Choi, Y.H., G.Y. Jin, H.S. Guo, H.M. Piao, Li. Lc, G.Z. Li, Z.H. Lin, and G.H. Yan. 2012. Silibinin attenuates allergic airway inflammation in mice. Biochemical and Biophysical Research Communications 427(3): 450–455.
Boeckenholt, C., F. Begrow, and E.J. Verspohl. 2012. Effect of silymarin and harpagoside on inflammation reaction of BEAS-2B cells, on ciliary beat frequency (CBF) of trachea explants and on mucociliary clearance (MCC). Planta Medica 78(8): 761–766.
Hwang, J.W., S. Rajendrasozhan, H. Yao, S. Chung, I.K. Sundar, H.L. Huyck, G.S. Pryhuber, V.L. Kinnula, and I. Rahman. 2011. FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary disease. Journal of Immunology 187: 987–998.
Arnson, Y., Y. Shoenfeld, and H. Amital. 2010. Effects of tobacco smoke on immunity, inflammation and autoimmunity. Journal of Autoimmunity 34(3): J258–265.
Kirkham, P., and I. Rahman. 2006. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacology and Therapeutics 111(2): 476–494.
Altaei, T. 2012. Protective effect of silymarin during coronary artery bypass grafting surgery. Experimental and Clinical Cardiology 17(1): 34–38.
Hou, Y.C., K.T. Liou, C.M. Chern, Y.H. Wang, J.F. Liao, S. Chang, Y.H. Chou, and Y.C. Shen. 2010. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation. Phytomedicine 17(12): 963–973.
Zhao, J., M. Lahiri-Chatterjee, Y. Sharma, and R. Agarwal. 2000. Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis 21: 811.
Bosisio, E., C. Benelli, and O. Pirola. 1992. Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacological Research 25: 147.
Soto, C., R. Recoba, H. Barrón, C. Alvarez, and L. Favari. 2003. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comparative Biochemistry and Physiology C-Toxicology & Pharmacology 136: 205.
Zhao, J., R. Harper, A. Barchowsky, and Y.P. Di. 2007. Identification of multiple MAPK-mediated transcription factors regulated by tobacco smoke in airway epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 293: L480–490.
Junttila, M.R., S.P. Li, and J. Westermarck. 2008. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB Journal 22: 954–965.
Cossa, G., L. Gatti, G. Cassinelli, C. Lanzi, N. Zaffaroni, and P. Perego. 2013. Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway. Current Pharmaceutical Design 19(5): 883–894.
Renda, T., S. Baraldo, G. Pelaia, E. Bazzan, G. Turato, A. Papi, P. Maestrelli, R. Maselli, A. Vatrella, L.M. Fabbri, R. Zuin, S.A. Marsico, and M. Saetta. 2008. Increased activation of p38 MAPK in COPD. European Respiratory Journal 31: 62–69.
Rahman, I., and W. MacNee. 1998. Role of transcription factors in inflammatory lung diseases. Thorax 53: 601–612.
Chung, K.F. 2011. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest 139: 1470–1479.
Gaffey, K., S. Reynolds, J. Plumb, M. Kaur, and D. Singh. 2013. Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs. European Respiratory Journal 42(1): 28–41.
Mehra, D., P.M. Geraghty, A.A. Hardigan, and R.A. Foronjy. 2012. Comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PloS One 7(12): e52889.
Acknowledgments
This study was supported by grants 31171103 and 81230001 from the National Natural Science Foundation of China and 06–834 from the China Medical Board of New York to Dr Fu-Qiang Wen.
Conflicts of Interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, D., Xu, D., Wang, T. et al. Silymarin Attenuates Airway Inflammation Induced by Cigarette Smoke in Mice. Inflammation 38, 871–878 (2015). https://doi.org/10.1007/s10753-014-9996-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-9996-9